Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura

Acquired thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease characterized by thrombotic microangiopathy leading to end-organ damage. The standard of care (SOC) treatment is therapeutic plasma exchange (TPE) alongside immunomodulation with steroids, with increasing use of rituxim...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2021-02, Vol.137 (7), p.969-976
Hauptverfasser:	Goshua, George, Sinha, Pranay, Hendrickson, Jeanne E., Tormey, Christopher, Bendapudi, Pavan K., Lee, Alfred Ian
Format:	Artikel
Sprache:	eng
Schlagworte:	Thrombosis and Hemostasis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!